The impact of depleted uranium (DU) on human health has been the subject of much conjecture. Both the chemical and radiological aspects of its behaviour in the human body have previously been investigated in detail, with the radiological impact being assumed to be linked to the alpha decay of uranium. More recently, it has been proposed that the accumulation in tissue of high-Z materials, such as DU, may give rise to enhanced local energy deposition in the presence of natural background photon radiation due to the high photoelectric interaction cross sections of high-Z atoms. It is speculated that, in addition to producing short-range photoelectrons, these events will be followed by intense Auger and Coster-Kronig electron emission, thereby causing levels of cell damage that are unaccounted for in conventional models of radiological risk. In this study, the physical and biological bases of these claims are investigated. The potential magnitudes of any effect are evaluated and discussed, and compared with the risks from other radiological or chemical hazards. Monte Carlo calculations are performed to estimate likely energy depositions due to the presence of uranium in human tissues in photon fields: whole body doses, organ doses in anthropomorphic phantoms and nano-/micro-dosimetric scenarios are each considered. The proposal is shown generally to be based on sound physics, but overall the impact on human health is expected to be negligible.
INTRODUCTION
This paper addresses the specific issue of whether doses and radiological risks from 238 U may have been substantially underestimated by neglecting the production of short-range secondary electrons produced by uranium atoms, or micro-/nano-sized particles of uranium, following interactions with natural background photons. It has been suggested that the additional localised dose around uranium atoms or micro-/nano-particles could be sufficiently large to account for a range of health effects, not previously attributed to uranium on the basis of its radiological or chemical toxicity (1 -3) . The proposal is that the proportional risk is greatest for 238 U, since its alpha activity is low relative to those of 234 U or 235 U; it constitutes 99.3 % of natural uranium and an even higher fraction of depleted uranium (DU). These proposed effects have been investigated by other authors: for example, Pattison et al. (4) showed a small enhancement effect around uranium particles. The maximum dose enhancement reported (4) was a factor of 3.3, orders of magnitude lower than the enhancement suggested by Busby (1, 2) . Enhanced biological effects near the interfaces between high-Z materials and tissue, following highdose irradiation, have been known and studied for decades: for example, the effect has been shown to cause burns and necrosis in tissue around reconstructive wires in mandibular cancer patients following radiation therapy (5) . The use of high-Z materials for dose enhancement in cancer radiotherapy was first advanced by Matsudaira et al. (6) , based on studies of the effect of iodine on cultured cells. Since then several authors have reported similar results: Regulla et al. (7) showed substantial increases in dose and effects on fibroblast monolayers cultured on gold foil; Herold et al. (8) injected gold particles (1.5 -3.0 mm diameter) into tumour tissue and demonstrated increased effectiveness of radiation in reducing cell viability; Hainfield et al. (9, 10) used intravenous injections to deliver large numbers of gold nanoparticles to tumours in mice, resulting in a dramatic increase in the effectiveness of 250 kVp X-ray therapy. In all of these cases, effects were recorded after exposing the materials to high photon fluences.
Reliable estimates of uranium toxicity are important in the contexts of its use in the nuclear industry and in the use of DU munitions, and also in the assessment of doses to members of the public, since all humans are exposed to natural uranium in their diets. The toxicity of DU has been the subject of a number of reviews because of suggestions that it may be associated with health effects experienced by military personnel (11 -15) . In each case, it was concluded that radiation from DU was not responsible for any observed effects. While these analyses considered the available biological data on risks from # Crown copyright 2012.
Radiation Protection Dosimetry (2012), Vol. 151, No. 2, pp. 323-343 doi:10.1093/rpd/ncs013 Advance Access publication 28 May 2012 uranium, they did not consider the possibility of dose enhancement from natural background radiation as proposed by Busby (2) . In this study, the possible extent of dose enhancement around uranium particles of respirable sizes that might result in lung cancer is addressed. Doses to other tissues are considered, particularly to the kidneys where uranium is retained prior to excretion, and from absorbed, soluble forms of uranium. The implications of uranium binding to DNA are also addressed.
PHOTON INTERACTIONS WITHIN TISSUE AND URANIUM
Plotting the photon cross sections (16) in barns per atom for ICRU 4-element tissue and uranium shows that the interaction cross sections for uranium are substantially higher ( Figure 1 ). These data for tissue have been produced directly from the XCOM database on the National Institute of Standards and Technology (NIST) website (16) by defining ICRU tissue as a compound. In their raw state, they are provided in cm 2 g 21 , but those data have been divided by the total atoms per cm 3 to convert to barns per atom.
The photon interaction cross sections in barns per atom are significantly higher for uranium than for tissue because photoelectric events and Compton scattering are both interactions with atomic electrons and there are 92 electrons in a uranium atom and about 3.4 per atom on average in ICRU 4-element tissue. When plotted for photon energies greater than 1 keV, the cross sections for tissue are smooth, whereas those for uranium show features linked to the atomic shell structure ( Figure 1 ): all of the electrons in ICRU 4-element tissue have binding energies ,1 keV.
Photoelectric and Compton scattering events both produce secondary electrons which have the potential to cause further ionisation. The energy of the secondary electron will be dependent on the energy of the incident photon, the binding energy of the electron and for Compton scattering, the angle of the scatter; consequently, both interactions produce a wide range of secondary electron energies. Both interactions are also followed by the similar electronic relaxation processes that accompany an atomic vacancy: fluorescence, Auger emission and CosterKronig emission. However, photoelectric interactions are more likely to produce inner shell vacancies, so they will on average produce more short-range photons and electrons during electronic relaxation. Figure 1 provides a clear illustration of the basis for the inference that the presence of uranium in the body might cause significantly increased risk owing to its very high photon interaction cross sections. However, high-dose tissue reactions (5 -10) do not imply that significant stochastic effects would be observed at low-photon dose rates. The proposed effects (1, 2) are based on the photoelectric cross sections being proportional to Z 4 , which would give a ratio of 540 000 between the cross sections for uranium (Z¼92) and tissue (mean Z 3.4). However, the mean Z per atom in a compound is not the relevant comparison in this context, because if the cross sections are proportional to Z 4 , the effective Z of the compound in terms of its cross section needs to be calculated using the average Z
4
. This gives a value of 6 for the effective Z of tissue, which gives a Z 4 ratio of 55 000, an order of magnitude lower than that based on the mean Z. In practice, however, the maximum ratio for the total cross sections is a further order of magnitude lower, with the maximum being a factor of just over 5000 at 21.8 keV (Figure 1 ). This is caused by the dominance of Compton scattering in tissue for photon energies .20 keV.
However, while a fixed ratio may provide a rough estimate, in practice, the ratio will be dependent on photon energy: the atomic shell structure of the atom influences the cross section strongly, because photons that have less than the binding energy of a given shell cannot produce photoelectrons from that shell. Consequently, a Z 4 relationship does not hold for high-Z atoms for lower photon energies (Figure 2 ), because these photons can only undergo photoelectric interactions with outer-shell electrons. It hence follows that the potential for such events to produce a multiplicity of Auger and Coster-Kronig electrons is also reduced significantly.
When the ratio of the photoelectric cross sections to the ratio of the fourth powers of the atomic numbers is plotted for uranium and tissue as a function of photon energy (Figure 3) , it is found that the proposed (1, 2) 540 000 ratio is never reached if a Figure 1 . Photon cross sections for ICRU 4-element tissue and uranium. The total has been plotted with coherent scattering omitted. Partial cross sections are plotted for photoelectric absorption and Compton scattering (16) .
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mean Z of 3.4 is used for tissue. If a value of 6 is used for the mean Z, then the predicted ratio for the cross sections is only exceeded above the uranium K-edge (116 keV). For lower energies, the ratio is substantially lower than would be predicted from the Z 4 ratio because some of the atomic electrons in uranium are bound too tightly for them to undergo photoelectric interactions: at 1 keV, the ratio is a factor of 10 4 lower than would be predicted on the basis of the 92 4 :3.4 4 ratio. Photon cross sections are often considered in terms of the related mass attenuation (m/r), massenergy transfer (m tr /r) and mass-energy absorption (m en /r) coefficients (17) , because in practical radiation protection these functions can be useful for calculating attenuations and absorbed doses (16) . At any given energy, the mass attenuation coefficient of a material is proportional to its total cross section for photons, which is in turn calculated by summing all of the individual cross sections for the different interactions that may take place: photoelectric, incoherent (Compton) scattering, coherent (Rayleigh) scattering, pair/triplet production and photonuclear interactions (note that photonuclear data are not included in the NIST database (16) or Figure 1 , but they should contribute for energies above 6 MeV for uranium).
The mass-energy transfer coefficient is related to (m/r), but with the individual interaction cross sections weighted according to energy-dependent functions that account for the resulting kinetic-energy transfers to the charged secondary particles. Massenergy transfer coefficients are used in the determination of kerma (Kinetic Energy Released in MAtter). The mass-energy absorption coefficient is proportional to (m tr /r), correcting for energy carried far from the point of interaction by electromagnetic radiation emitted as a result of secondary charged particle stopping (Bremsstrahlung) and inflight positron annihilation. However, this adjustment for radiative emission is small for particles below a few MeV, especially in relatively low-Z material (18) , so for these energies (m en /r) approximates (m tr /r); use of (m en /r) is therefore generally accepted as being reliable for the assessment of kerma, and hence absorbed dose, under appropriate conditions.
The ratio of the mass-energy absorption coefficients of pure uranium and ICRU 4-element tissue reaches a maximum of .200 around 50 keV (Figure 4) . Similarly, for tissue contaminated with uranium, the impact on the mass-energy absorption coefficients, and hence on the energy deposited in the body, is also greatest around 50 keV. However, when considering a concentration of uranium in ICRU tissue of 1 mg g
21
, which would be chemically toxic, the resulting increase in the mass-energy absorption coefficients peaks at only 22 % at 40 keV and is much lower for most of the energy range considered ( Figure 4 ). For more realistic levels of contamination, the maximum increase due to uranium would be ,1 %. ICRU 4-element tissue is a simple approximation of tissue that is used in the definition of dose equivalent quantities. More realistic definitions of tissues (19, 20) include trace elements, some of which are considerably higher in Z than the components of ICRU 4-element tissue, iron (Z¼26), calcium (Z¼20) and iodine (Z¼53) being notable examples. The inclusion of such trace elements in the comparisons would narrow the gap between uranium and tissue, but the difference would be very small. (6) and uranium (92). Figure 3 . Ratio of the ratios of the photoelectric cross sections for uranium and tissue, to the ratio of the fourth powers of the atomic numbers of uranium and tissue, versus photon energy. The horizontal line represents the anticipated value if the suggestion is valid that the photoelectric cross section ratio for uranium to tissue is equal to Z 4 . Data are presented for the ratio using the mean Z of 3.4 and the effective Z of 6 for tissue.
MODELLING OF DOSE DEPOSITIONS AROUND URANIUM MICROPARTICLES
When considering occupational exposures to uranium or the exposure of military personnel to DU, the main route of intake into the body is the inhalation of microscopic particles (12, 13, 14, 21, 22) . For members of the public, ingestion could also be an important route for intake. A proportion of inhaled material is escalated from the lungs and enters the alimentary tract. A wide range of particle sizes could be generated by the use of DU munitions, with the differences arising in part by the mechanism by which the microparticles are generated: when they have been formed by nucleation and grown following vaporisation, they are likely to have sub-micron diameters, but airborne particles produced by fragmentation of the original material are likely to have diameters of a few microns or greater (12) . To investigate the suggestion that natural background photon irradiation of uranium nano-/microparticles may lead to substantial localised energy deposition, in addition to that resulting from alpha decay, the effect was assessed for a range of particle sizes embedded in tissue. The Monte Carlo code MCNP5 version 1.40 (23) was used to model dose deposition in the presence and absence of uranium particles, considering first exposures to a directed source to estimate the maximum possible effects, and then an isotropic source, which corresponds to a more realistic exposure condition. A summary of the results was presented at the 15th International Symposium on Microdosimetry (24) .
Natural background photon energy distribution
Since the proposed effect is attributed to natural background photons, it was important for the models to be exposed to an energy distribution that can be taken to be an approximation for 'natural background' ( Figure 5 ). The field used was measured at Health Protection Agency (HPA), Chilton using a germanium spectrometer (25) . It has not been deconvolved to account for events that do not deposit the full photon energy, nor has it been corrected for detector efficiency. Both of these factors will cause the high energy part of the energy distribution to be underestimated. The magnitude of these effects has not been determined for the detector used for this measurement, but it has been shown (26) that the efficiency for the 40 K peak, visible at 1460 keV in Figure 5 , is 10 % relative to the efficiency around 100 keV. For higher energies, the efficiency is likely to be a further factor of two lower. Below 100 keV, there is a slow fall in the efficiency to 46.5 keV (26) , the lowest energy used in the citation. Below 46.5 keV the use of an aluminium window on the detector will significantly attenuate incident photons with low energies, especially around the K-edge for aluminium at 1.56 keV. Consequently, this energy distribution is only intended as a representation of a background field; one which should give a conservative estimate Figure 4 . Comparison of the mass-energy absorption coefficients for uranium and ICRU 4-element tissue (16) . The lower part of the figure shows a direct comparison. The upper part of the figure gives the mass-energy absorption coefficient ratios for: uranium to ICRU 4-element tissue; ICRU 4-element tissue with uranium contamination to that for pure ICRU 4-element tissue. A contamination of 1 mg uranium per g of tissue has been considered, in order to exaggerate any effect, but the increase in the absorption coefficient remains 22 %. Figure 5 . The natural background photon energy distribution at HPA Chilton, with the value in each bin normalised to the total fluence. The energy bins have a width of 3.7 keV (25) . This energy distribution was used as the background photon field for the Monte Carlo calculations in this work.
of the effects that are being considered, because the true field will include more high-energy photons. The energy distribution and dose rate from natural background are both dependent on geographical location. However, there is no available database of natural background energy distributions, so it is not possible to extend the results in this work to cover every possible natural background field. If a field had a considerably lower mean energy than the one used in this work, then it could be that photoelectric interactions on high-Z materials would be more significant than has been assessed using this example field. Conversely, if the mean energy were higher, the photoelectric effect might be less significant.
The field incident on a microparticle within body tissue will depend on its location in the body: a slight reduction in the mean photon energy will occur with increasing depth in tissue. In practice, this is not a very significant effect because the photons that are downscattered in energy have higher attenuation coefficients, causing them to be absorbed more strongly. At many locations within the body, the fields may therefore be expected to be roughly similar to the incident background distribution. In the anthropomorphic models used in this work these effects will be taken into account, but in calculations using thin layers of tissue around microparticles they will not be fully accounted for. It is not anticipated that neglecting the full downscatter has had a significant impact on the accuracy of the results shown below, especially for those models in which at least 10 mm of surrounding tissue was incorporated.
Directed source
The basic configuration modelled consisted of three concentric spheres, labelled the 'microparticle', the 'cell' and the 'surroundings', located in vacuo. The materials of the cell and surroundings were defined as ICRU 4 -element tissue (27) , which is defined as having unit density. The cell layer had a radius of 10 mm, to represent either a layer of cells surrounding the particle or a single large cell containing a particle. The surroundings had a radius of 10 mm, which corresponds to the depth of tissue relevant to the protection quantity H p (10) (27) . Microparticles with diameters from 0.1 to 3 mm were considered, with their composition defined either as pure uranium (18.95 g cm 23 ) or ICRU 4-element tissue: when results from the two cases were compared, effects caused by the presence of uranium could be evaluated. Specifically, the dose-enhancement factor was estimated by dividing the combined photonþ electron dose deposited in a given region of interest (e.g. the cell layer) when a uranium microparticle was present, by the photonþelectron dose deposited in the same volume when the uranium was replaced by tissue. The radioactivity of the uranium was temporarily ignored.
The photons were emitted radially inwards from a concentric spherical surface of radius 11 mm. If interactions in the tissue could be neglected, every source photon would thus be incident upon the microparticle; in this way, an artificial, 'worst-case' scenario was modelled. Full electron/photon transport was employed in the calculations, with the relevant MCNP parameters defined appropriately to accurately model electron transport through the microscopic configuration. The presence and impact of photons and electrons in the microparticle, cell and surrounding regions were registered using MCNP fluence ('f4') and energy deposition ('*f8') tallies, as appropriate. Doses were determined by dividing the energy deposition result tallied in each region by its mass. The resulting dose-enhancement factors are shown for the cell layer in Figure 6 and for the surrounding tissue in Figure 7 , as a function of microparticle size. The standard uncertainties caused by the Monte Carlo statistics in the radial case are generally too small to resolve, being at most 1 %.
Figures 6 and 7 show that, for this contrived, worst-case irradiation from a directed source, the model predicts a maximum increase in the dose due to the presence of the uranium particle by a factor of about 20 in the 10 mm radius cell layer and by a factor of about 1.03 in the 10 mm of surrounding tissue. In both cases, the enhancement ratios tended to unity as the radius of the microparticle was decreased, as would be expected. Also in both cases, a 'plateau' started to become evident as the radius of the microparticle was increased. This plateauing is Figure 6 . Dose enhancement factor in the 10 mm radius cell layer, as a function of particle size, for a radially oriented photon source with a natural background energy distribution.
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caused by the increase in the self-absorption of secondary radiation within the microparticle: a 10 keV electron, for example, has a range in uranium of only 0.5 mm (28) so relatively few of the low energy Auger and Coster-Kronig electrons generated in a 1 mm radius microparticle will escape from it.
Isotropic source
The configuration modelled in the second set of calculations was similar to that used for the simulations involving a radially directed source, described above. The major difference was the redefinition of the source as a sphere of radius 11 mm, with photons emitted isotropically inwards from its surface, which represents more realistic exposure to photons from natural sources. Without interactions, the field would have been isotropic and homogenous everywhere within this sphere. Modelling an isotropic field incident on the microparticle/tissue configuration was assumed approximately to reflect the situation likely to occur in nature; in reality, of course, the orientation and geographical location of a person, and the position of the microparticle within their body, would cause deviations from isotropy, but for the purposes of the present analysis such potential nonuniformities were disregarded.
The reduction of the radius of the source was necessary for successful Monte Carlo simulation: had the radius remained 11 mm, for example, almost all of the photons modelled would have 'missed' the microparticle, leading to very poor statistics. As for the calculations for a radially directed source, the material of the microparticle was defined either as pure uranium or as ICRU 4-element tissue, with its radius varied in order to investigate dose enhancement as a function of particle size. MCNP *f8:p,e tallies were again used to estimate energy depositions. The resulting dose enhancements for the cell layer with 10 mm radius are shown in Figure 8 , expressed as the ratios of absorbed dose when the uranium microparticle was present to that when it was replaced by tissue. The behaviour of the dose-enhancement factor as a function of particle radius is different from that observed for the inward radially directed source ( Figure 6 ): in an isotropic field the gradient increases with increasing particle size, whereas for the radial source the gradient decreases to a plateau; these differences are discussed later.
For uranium particles of a given radius, the spatial distribution of dose enhancement through the cell layer has also been investigated. To achieve this, the cell layer was sub-divided into a set of 10 concentric sub-shells, with outer radii: 1, 2,. . .,10 mm. Focusing attention on a particle of 0.5 mm radius that is exposed to the isotropic source, with the assumption made that the results obtained could be scaled to other sizes using the data from Figure 8 , the enhancement factor in each of the layer's 10 sub-shells can be plotted ( Figure 9 ). These results show that the absorbed dose enhancement is greatest close to the microparticle, which is to be expected because the secondary radiation generated within the uranium is relatively short-range. Consequently, this enhancement must tend to 1.0 (i.e. no enhancement) at large distances from the microparticle.
Radial versus isotropic field
The dose enhancement in a 10 mm tissue layer for an isotropic photon field approaches unity as the Figure 7 . Dose enhancement factor in the 10 mm radius surrounding tissue, as a function of particle size, for a radially orientated photon source with a natural background energy distribution. Figure 8 . Dose enhancement factor in the cell layer of 10 mm radius, as a function of microparticle size, in an isotropic photon field with a natural background energy distribution. The relative photon fluence through the microparticle of 1mm diameter was tallied at 2.63Â10 5 cm
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per-source-photon.
R. J. TANNER ET AL.
radius of the uranium particle decreases ( Figure 8 ); this is as expected, and was similarly observed for a radially directed field ( Figure 6 ). For larger radii, however, the 'plateau' seen in the cell dose enhancement for a directed source was not observed for isotropic source exposures. The difference in behaviour is caused by geometric factors associated with the different source geometries. In both cases, the energy released is proportional to the average track length of a photon in the microparticle, which is a function of the particle radius (r): if attenuation of the source photons is ignored the average track length in the microparticle in the radial case is 2r, while that for the isotropic case is 4r/3. This result for the isotropic case has been calculated using the track length estimator of fluence in MCNP for the microparticle cell and ignores particles that do not impinge on the microparticle. However, the radial and isotropic exposures differ in another important respect: for the radial case the number of photons incident on the microparticle is independent of its radius, i.e. is constant with changing r, whereas for the isotropic case it is proportional to the surface area of the microparticle, and hence on r 2 . When these factors are combined with the relationships for average track length, it can be seen that for the radial case the kerma in the microparticle is proportional to its radius, whereas for the isotropic case it is proportional to the cube of the radius. This analysis assumes that the photon field is not attenuated appreciably by the microparticle, so these simple expressions for kerma become less valid as the microparticle radius increases.
The radial distributions of energy released within the microparticle are also significant. Specifically, the depth of a photon interaction within the microparticle affects the attenuation of the secondary electrons emitted. A secondary electron needs to escape from the microparticle to be biologically significant, but this can only happen if its range is greater than the distance to the particle surface in the direction that it is travelling. On average, electrons are produced further from the surface of the microparticle in the radial case than in the isotropic case, because in the former every photon track passes through the centre of the microparticle, whereas in the latter the photon tracks tend to be 'shallower'. However, as a general rule, when the microparticle radius is increased, the average electron attenuation within the microparticle also increases.
Overall, as the microparticle expands beyond a size that is significant relative to the ranges of the secondary electrons, the increase in photoelectron production due to lengthening photon tracks begins to be cancelled out by the concurrent increase in the number of electrons that are subsequently absorbed. That is, electrons created deep within the microparticle become increasingly less able to escape, such that only those produced closer to its surface contribute to the dose enhancement; only those electrons created in the outermost region of the microparticle can be biologically relevant, where the thickness of this shell correlates with the maximum electron range. This leads to the equilibrium approached for the radial exposure (Figure 6 ), where further increases in microparticle size do not result in greater dose enhancements in the tissue. But for the isotropic case, the number of photons incident on the microparticle, and hence available to liberate electrons in this important region, increases as its radius increases, so no plateau is observed in the tissue dose enhancement (Figure 8 ). For larger microparticle radii, it is anticipated that self-attenuation of the secondary radiation by the microparticle may be proportional to the radius of the microparticle, so the dose-enhancement factor may exhibit an r 2 dependency. Some of these general statements about the functionality expected for the dose enhancement for the radial and isotropic cases can be illustrated using simple approximations: i.e. that, if attenuation of the primary and secondary radiation fields within the microparticle are ignored, the dose enhancement will be proportional to the microparticle radius for the radial case and proportional to the radius cubed for the isotropic case. Linear and cubic fits applied to the first three points for the radial and isotropic cases, respectively show significant deviations from the calculated data when extrapolated (Figure 10 ), which may show that attenuation within the microparticle is causing the dose enhancement to be smaller than the simple linear and cubic relationships predict (Figure 10 ). No physical significance Figure 9 . Absorbed dose enhancement factors in the 10 sub-shells comprising the cell layer, for a uranium particle of 0.5 mm radius that is exposed to an isotropic natural background photon field.
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should be attributed to the fits, since they are only intended as guides that approximate to the expected functionality in the absence of scatter and attenuation. It is acknowledged that the plotted fits would be different if more data points were used.
Electrons emerging from a microparticle
By tallying the fluence (i.e. defining MCNP 'f2:e' and 'f2:p' tallies) on the surface of the uranium particle in 1 keV increment bins, the distributions of electrons and photons that emerge from it when exposed to the natural background photon field could be estimated. For these calculations, the cell layer was omitted and the radii of the sources were reduced to 0.7 mm, to further enhance statistical precision. The 1 keV minimum energy in MCNP for photon and electron transport means that very low energy particles are assumed to be absorbed where they are created. The distributions of electrons emerging from a 1mm diameter uranium particle and from the same volume of tissue are plotted in Figure 11 ; the data are for a natural background photon energy distribution. The absolute values of the fluence depend strongly on the radius of the source field; Figure 11 should therefore primarily be viewed as providing a comparison between uranium and tissue. The photon energy distributions in the two cases were found generally to be statistically irresolvable from one another and from the background, within the energy range over which the latter was defined ( Figure 5 ), with differences greater than a few % exhibited in only a very few bins; moreover, none of these were more than 10 %, and all occurred at high energies where the fluence is less well-sampled. This indicates that the contribution to dose enhancement from secondary photons is insignificant.
It was found ( Figure 11 ) that the presence of uranium increased the electron fluence emerging from the microparticle in an energy-dependent manner. Specifically: † The electron fluence falls strongly below 30 keV for the uranium microparticle but not for tissue. This will be caused in part by the difficulty that low-energy electrons have in escaping from the uranium microparticle, but it may also be caused by fewer electrons being emitted in this energy range. † Between a few 10s to a few 100s of keV, the electron fluence emerging from the uranium particle is about three orders of magnitude higher than that emerging from tissue. This is the energy range where photoelectric interactions dominate in uranium, so this increase is probably caused primarily by the increased photoelectric cross section of uranium relative to that of tissue. † For the higher energies, the electron fluence ratio is about two orders of magnitude higher for uranium than tissue. This ratio is smaller than for lower energies due to the increased contribution from Compton scattering.
The size of the microparticle affects the electron energy distribution that emerges from it. Generally, the mean energy of this distribution will increase with particle radius, because low-energy electrons Figure 10 . Dose enhancement factor for the 10 mm cell layer versus microparticle radius for both the inward radial and isotropic source geometries. The fits to the data are intended only to indicate the effects of attenuation within the microparticle, they are not to be accorded physical significance: they represent the anticipated relationships for energy deposition within the tissue layer, if attenuation of the source photons and secondary electrons can be ignored. Figure 11 . Fluence distributions of electrons emerging from a uranium particle of radius 0.5 mm and from the same volume of tissue, surrounded by vacuum and exposed to an isotropic natural background photon field. The data in each 1 keV bin were normalised to the total electron fluence emitted from the tissue. The 'noise' at higher energies is due mainly to increasing MCNP statistical variances. generated deep within the particle will be attenuated, whereas higher energy electrons will escape with relatively little loss of energy. It may hence be inferred that small microparticles represent the case where the dose enhancement is most localised.
Annual doses from photoelectric effect and alpha decay
The results obtained for dose enhancement need to be placed in context: it is helpful to consider the absolute increase in energy deposited in the cell layer due to the presence of the uranium and to relate this to the natural background photon fluence that uranium particles are likely to experience in the human body. To explore this, the configuration featuring a 1mm diameter uranium particle exposed to the isotropic field was analysed, with the assumption made that the results could be scaled to other particle sizes using the data from Figure 8 : given the approximate nature of this calculation, that assumption was considered to be justified. The photon fluence in the microparticle was estimated using an MCNP fluence tally ('f4:p') defined as occupying the same volume as the microparticle. A relative photon fluence incident on the microparticle of 2.63Â10 5 cm 22 per-source-particle was obtained (statistical uncertainty ,0.1%). The energy deposited (MCNP '*f8:p,e' tally) in the cell layer was found to be 1.06 (+0.01) eV per-sourceparticle, which compared with a deposition of 0.996 (+0.011) eV per-source-particle when the uranium particle was replaced by tissue; a dose-enhancement ratio of 1.06 is thus calculated for 1mm diameter microparticles, as seen in Figure 8 . Thus, when a 1 mm diameter particle is exposed to a photon fluence of 2.63Â10 5 cm 22 , the presence of uranium instead of tissue increases the average energy deposited in the cell layer by 64 MeV. This value represents an average: in a year some microparticles would have no interactions with natural background photons, but for those that do, the energy deposited might be greater than this value.
To ascertain the significance of this result, it is necessary to relate it to the natural background photon fluence rate. In order to provide a rough, order-ofmagnitude estimate, two basic assumptions were made for the background: † It can be approximated as a monoenergetic field of energy 100 keV (cf. Figure 5 ). † The effective dose typically obtained from exposures to natural background photons is 1 mSv per year (29) .
From data given by ICRP (30) and ICRU (31) for conversion from fluence to air kerma and air kerma to E, the fluence to effective dose conversion coefficient for 100 keV photons can be taken to be 0.52 pSv cm 2 for antero-posterior (AP) exposure. Using this value, and from the assumption that 100 keV photons can be taken to constitute the natural background field, and hence lead to an annual effective dose of 1 mSv, a natural background fluence rate of the order of 10 9 cm 22 y 21 can thus be derived. So, for a 1mm diameter uranium particle, it can be concluded that if a photon fluence of 2.63Â10 5 cm 22 led to the average energy deposited in the cell layer being increased by 64 MeV, a background fluence rate of 10 9 cm 22 y 21 would lead to an increase in average energy deposition in the cell layer of about 100 eV y 21 . This order-of-magnitude estimate is robust for variations in the mean energy of the background of at least +50 %: it can be shown that if the background were instead assumed to be, for instance, either a 50 or 150 keV monoenergetic field, it would lead to the same order of magnitude result.
The significance of average energy deposition in the cell layer around uranium particles being increased annually by up to 100 eV should be considered in the context of the concurrent average energy deposition by alpha particles emitted by uranium isotopes. Considering a 1mm diameter, spherical particle of pure 238 U (half-life 4.468Â10 9 y (32) , density 18.95 g cm 23 , mass 9.9Â10 212 g and hence containing 2.5Â10 10 atoms), the expectation would be 4 decays per year, the primary mode of which would be via the emission of a 4.2 MeV alpha particle. This alpha particle would have a range of 30 mm in tissue (7 mm in uranium) and its energy deposition would average 0.1 MeV mm 21 in tissue (33) . Thus, the alpha decay of a 1mm diameter 238 U particle can be expected to deposit 4 MeV on average in the surrounding cell layer within a year, which compares with 100 eV y 21 resulting from the microparticle's interactions with the natural background photon field. This comparison ignores the substantial additional energy depositions resulting from subsequent decays of the daughter nuclei in the 238 U decay series, as well as from the many atomic relaxation processes that would follow each alpha decay. Moreover, it also disregards contributions from any other contaminants that might be present in a microparticle, such as the more active 235 U. It should also be noted that all of these calculations have assumed pure uranium particles; effects would be lessened by the more realistic assumption that the metal would be at least partially oxidised.
Uranium particles in the respiratory and alimentary tracts
To examine the possible importance of secondary photoelectron emissions from uranium particles, dose enhancement and energy deposition were considered for a layer of cells packed around a microparticle. In practice, this will not be a common occurrence in the respiratory tract and is even less likely in the alimentary tract where the majority of particles will be at some distance from the cells considered to be the targets for induction of cancer (21, 22, 34) . The depth of target cells in the airways of the lungs is 30-40 mm from the mucus layer in which particles are deposited and the corresponding depth of target cells in the colon is 280 -300 mm. However, encapsulation of particles within tissue may occur, particularly in the alveolar region of the lungs (11, 34, 35) . To evaluate dose enhancements in cells far from the microparticle, the model used to calculate the dose around a microparticle was modified such that the tissue was sub-divided into a set of 40 concentric sub-shells, with outer radii fi mm, for i ¼ 1,2,. . .,10 and i ¼ 20, 30,. . .,300 and i ¼ 10 000g. An inward radially directed, natural background photon distribution was again used and the energies deposited in each sub-shell were estimated using *f8:p,e tallies, with a uranium microparticle present or replaced by tissue. The resulting dose-enhancement profile through the tissue is shown in Figure 12 for a microparticle of 0.5 mm radius. The distribution of dose enhancement is roughly linear initially on log-log axes, before tending asymptotically to unity for subshells of larger radii.
Repeating the simulations but using an isotropic source is problematic, and all computations attempted led to unacceptably high statistical uncertainties on the results. However, for a microparticle of 0.5 mm radius, the comparison between the radial and isotropic sources (Figure 10) shows that the dose enhancement in the cell layer of 10 mm radius is over 10 times smaller for an isotropic source exposure than for a radial source. Additionally, the data in Figure 12 show that for exposures to the radial source, the dose enhancement in the 280 mm (inner radius) to 290 mm (outer radius) sub-shell is only 1.07 + 0.02, and 1.06 + 0.02 in the 290 mm (inner radius) to 300 mm (outer radius) sub-shell. It might therefore reasonably be expected that for isotropic source exposures, the dose enhancements in these outer sub-shells would be negligible. This suggestion is further supported by the data presented in Figure 9 , where a rapid decline towards unity is exhibited within just the first 10 mm of tissue. The overall conclusion must therefore be that cellular energydepositions at target cell locations would be insignificant if microparticles in the lumen of the colon were exposed to the natural background photon field.
Following the inhalation or ingestion of uranium particles, or ingestion of other forms of uranium, a proportion will be dissolved and absorbed into blood. The fate of this soluble uranium, probably present in the form of uranyl ions, and possible enhancement of dose due to the photoelectric effect, is considered in the following section.
Extension to macroparticles Figure 8 shows that, in an isotropic field, dose enhancement grows with increasing particle radius. This observation might be taken to indicate that the effect would be more severe for larger pieces of uranium, for example, DU shrapnel embedded in a wound. Because the rate of increase is increasing with particle radius, it might appear that the dose enhancement factor would become very significant for much bigger particles. However, direct extrapolation of these results to particles of large diameters would be misleading, because inherent in the definition of cell dose enhancement considered in the present work is the assumption that the dimensions of the microparticles are small compared with the sizes of the cells that surround them. For macroscopic particles, however, this assumption is no longer valid, so the models considered here do not accurately represent the relevant biological scenario. Consequently, analyses and conclusions based upon the present models should not be extrapolated too far beyond their limits.
Although not considered in depth in this report, for macroscopic particles the appropriate quantity to investigate would be something like the doseenhancement factor to cells that are located within a short distance from the uranium particle surface. But, it might be expected that this enhancement would be fairly independent of the size of such particles. This conclusion follows because for large diameters, the dimensions of the particles become much greater than the ranges of the electrons they emit: a 50 keV electron, for instance, travels 6 mm in uranium metal, while a 100 keV electron travels 17 mm. Consequently, self-attenuation by the microparticle will increase for increasing particle sizes, causing the rate of increase in dose enhancement in the cells adjacent to them to slow and Figure 12 . Dose enhancement profile in the tissue layer sub-divided into numerous sub-shells, for a uranium particle of 0.5 mm radius that is exposed to an inward radially directed natural background photon field. then stop. If the microparticle had millimetre dimensions, the dose enhancement from photoelectrons would be caused only by those emitted from the 20 mm-thick layer closest to its surface, because electrons generated deeper in the particle would not escape.
In an attempt to quantify some of these effects, a simple configuration was modelled consisting of a 1.0Â1.0Â0.5 mm 3 slab of uranium abutted to a 1.0Â1.0Â0.25 mm 3 slab of ICRU tissue, with a sphere of 10 mm radius defined in the tissue centred at a perpendicular distance of 10 mm from the interface of the slabs; this set-up was considered analogous to a eukaryotic cell located adjacent to one face of a piece of DU shrapnel. The configuration was exposed to the background photon field, emitted isotropically from a plane coincident with the 'front' face of the tissue slab, which was defined as the face parallel to the tissue-uranium interface. As in previous investigations, two calculations were performed: one in which the material of the 'shrapnel' was uranium, and one in which it was tissue. The energy deposited in the cell was tallied in both cases. An additional calculation was also performed to assess the fluence of primary photons incident on the uranium. For a tallied fluence of 44.7 cm 22 , it was found that the energy deposited in the cell was 10.7 + 0.4 MeV per-source-particle for uranium, and 1.01 + 0.04 MeV for tissue. The presence of uranium thus caused a dose-enhancement factor of 10.6 + 0.6 in the cell. This can be contrasted with the value of about three found for a 3 mm particle located within a cell (Figure 8 ).
When the annual exposure to the photon background field is taken into account, the increase in energy deposition of 9.7 + 0.4 MeV per-source-particle equates to an energy deposition rate in the cell of the order of 10 5 eV y 21 . This is 10 % of the 1 MeV that would be deposited by an alpha particle in travelling 10 mm in tissue. Within a 10 mm radius, 3 mm-thick cylindrical surface element of the uranium particle, it may be shown that there would be 10 000 alpha decays per year. In principle, each of these could deposit 1 MeV on average in a cell adjacent to the surface, although in practice their emission would be isotropic so only a fraction of these would hit the cell. Nevertheless, it may be inferred that the 0.1 MeV y 21 from enhancement by the photoelectric effect should be contrasted with a few GeV y 21 from alpha decay. Although the dose enhancement is evidently higher for macroscopic slabs than for microparticles, there are additional reasons for believing that large particles will not be of concern: † The most probable locations of these fragments would be in surface wounds, and hence away from sites of particular radiosensitivity. † It is perhaps reasonable to expect that large particles would not remain in the body for significant periods of time: they would likely be removed either during medical intervention (e.g. dressing of the wound) or, if inhaled or swallowed, by natural clearance mechanisms (e.g. coughing, egestion etc.). † The cells in contact with the microparticle embedded in the body are located within a wound so their long-term viability would be compromised, even without the enhancement of natural background photon dose rates and the much larger alpha decay dose rate.
Additionally, the extension to macroparticles rather than microparticles removes the possibility of the interactions taking place in close proximity to the DNA, since such particles cannot pass through the cell wall. High multiplicities of low energy, shortrange electrons are no longer an issue and inverse square considerations become more important.
SOLUBLE URANIUM RETAINED IN OTHER BODY TISSUES
Uranium absorbed by blood following inhalation or ingestion is mainly lost from the body via urinary excretion. Human and animal studies have shown that of uranium entering blood, about two-thirds is excreted in the first 24 h and roughly a further 10 % over the next 5 d (36 -41) . Most of the remaining uranium is excreted over a period of a few months, but a few per cent of the amount entering the blood may be retained by the body for a period of years, largely in mineral bone (41) . However, a substantial fraction of uranium filtered by the kidneys is temporarily retained in the renal tubules before passing into the urinary bladder. Morrow et al. (42) estimated that, 6 h after inhalation of UO 2 F 2 , the kidneys of beagle dogs contained 44 % of the uranium that reached the blood, and 16 % after 24 h. At 1-3 d after inhalation or injection of soluble forms of uranium, the kidneys of humans and animals contained 12-25 % of the amount entering the blood (39, 42 -45) . Durbin (46) reviewed data on the retention of uranium in the kidneys of humans and animals and concluded that 92 -95 % of the renal content present one day after ingestion/inhalation was lost with a half-time of 2-6 d, while the remainder was lost with a half-time of 30-340 d.
Most of the uranium retained in the skeleton is associated with mineral bone and is not incorporated into living cells. The kidneys are the main site of cellular retention of uranium and this is reflected in the chemical toxicity of uranium to the kidneys (14) . In the following sections, consideration is given to the proposed theoretical enhancement of dose (2, 3) on the basis of photoelectric cross sections, and Monte Carlo simulations are presented for uranium distributed throughout the whole body or retained in the kidneys. Finally, the issue of localised dose resulting from binding to DNA is examined.
Simple cylindroid phantom-whole body dose
The modelling so far has considered microscopic particles of uranium in small volumes of tissue. If, however, the uranium were ingested in soluble form, a proportion could become distributed through the body, requiring the contamination to be modelled in an anthropomorphic phantom. As a starting point for this part of the modelling, a uniform uranium contamination throughout the body was used. It is known that uranium would not be uniformly distributed, but these calculations were used to obtain a preliminary estimate of the magnitude of the effect.
For this simple calculation, it was not thought necessary to model the internal structure, the limbs or head. Consequently, the simplest 'realistic' model was constructed: a right-elliptical cylinder, or cylindroid, with a nominal mass of 70 kg. The height of the cylindroid was 111.4 cm (long-axis), its width 40 cm (major-axis) and its depth 20 cm (minoraxis). Only uniform irradiation from a direction parallel to the minor-axis, i.e. from the 'front' (AP), was considered.
These simple calculations were performed using MCNP5 (23) . The cylindroid phantom was exposed to plane-parallel photon sources, either monoenergetic with energies from 10 keV to 1 MeV, or with a natural background energy distribution. The phantom was composed of ICRU 4-element tissue either with or without uranium contamination; the absorbed doses in the phantom in the two cases were calculated and compared, in order to evaluate any dose-enhancement effects. The model used a contamination of 50 mg uranium per g of tissue, which equates to the level that would produce rapid kidney failure (13) , but the results can readily be scaled to approximate the results for any level of contamination. Good Monte Carlo counting statistics were easily achieved because the whole phantom could be used as a tally.
The maximum enhancement observed was 0.65 % in the whole body absorbed dose for 50 keV photons ( Figure 13) . For higher or lower photon energies, the increases were substantially lower: ,20 and .300 keV the increase in absorbed dose was ,0.1 %. The calculations were also performed using the natural background energy distribution ( Figure 5 ). This produced an increase of 0.1 % (1 standard uncertainty¼ + 0.01 %) in the absorbed dose for the whole torso at concentrations of 50 mg U per g tissue ( Figure 13 ). It was hence concluded that uniform distribution of uranium throughout the body cannot cause significant increases in absorbed dose, but it was not considered that these results alone ruled out the possibility that concentrations of uranium in specific organs may lead to organ doses that might be of concern.
Dose to the kidneys
To provide a more detailed determination of the possible magnitude of the enhancement of doses deposited in the human body due to natural background photon radiation interacting with uranium, calculations were performed using Monte Carlo modelling of anthropomorphic phantoms. Specifically, MCNPX version 2.5 (47) simulations were run using six different anthropomorphic phantoms: four voxelised (48, 49) and two MIRD-type (50) . The voxel phantoms were male and female pairs from the University of Pernambuco, Brazil (MAX06 and FAX06) (48) and GSF, Germany (GOLEM and LAURA) (49) , while the MIRD-type were hermaphrodites (NRPB18þand HPA18þ) (50) . ICRP have now recommended standard voxel phantoms for the calculation of organ doses and effective dose (51) . However, initial results indicate that the impact of these changes will be small for photons (51) , so the accuracy of the results given below should not be affected significantly by not using the new reference phantoms.
The simulations were performed by 'doping' the materials representing the phantoms' kidneys or lungs with small quantities of uranium, and exposing the configurations either to monoenergetic or natural background photon fields. The approach in Figure 13 . Ratio of the whole-body absorbed dose in a cylindroid phantom for 50 mg of 238 U per g of tissue uniformly distributed to the whole body dose with no uranium present. The data are presented for AP incidence for monoenergetic photons and also for the natural background energy distribution ( Figure 5 ). The contamination level is that at which rapid kidney failure would be expected.
each case was to perform two calculations: one with the uranium-contaminated organs, and one with 'normal', uncontaminated organs. Any doseenhancement effects due to the presence of uranium could thus be estimated by comparing the results. To provide a check on the method, the absorbed dose in the bladder wall was also calculated, with no uranium added, for both of the runs: these results showed no statistically significant differences and thereby provided reassurance that no errors had been introduced into the models which could have caused biases in the results. Concentrations of 50 mg U g 21 tissue were considered. Chemically, this is a dangerously high concentration: it is substantially in excess of the 1 -3 mg g 21 reported to have been associated with altered kidney morphology in rats and dogs (42, 52) , and represents a level that is likely to cause rapid kidney failure in humans (13) . ICRP did not include data for absorbed doses to the kidneys in their publication of conversion coefficients for external irradiation (30, 31) . However, data are available elsewhere (53) , albeit for non-standard voxel phantoms (Figure 14) . The conclusions of Sato et al. (53) were that absorbed doses in the kidneys are greatest for postero-anterior irradiation, as expected, with irradiation from the right, left or in isotropic fields producing only half as much absorbed dose.
The results in this section represent the mean absorbed doses determined by averaging the results from these six different phantoms. The kidneys are a relatively shallow organ when the body is irradiated from the back ( postero-anterior), so that geometry is likely to provide the worst-case scenario. However, natural background photons are never unidirectional so it was considered unrealistic to use that geometry with anthropomorphic phantoms. Instead, it was assumed that the natural background photon field is effectively isotropic, so an isotropic field was used in these calculations.
For photon energies of 30 keV and below, the photon fluence in the kidneys is negligible due to rapid attenuation of the source field by the intervening tissue: this is reflected in the very low-absorbed dose for such low energies (Figure 14) . Photoelectric enhancement by uranium for these energies is therefore not important when considering absorbed dose in the kidneys. The greatest potential dose enhancement due to Auger electrons from uranium may be expected to occur at photon energies just above its K-edge; that is, at around 120 keV, which is close to the fluence peak in the natural background photon energy distribution ( 100 keV). As a consequence, a 120 keV monoenergetic photon field was used as the source in the MCNPX simulations in the first instance. The results showed a significant, but small, enhancement of kidney dose of 0.5 % (standard uncertainty of 0.03 %) due to the presence of uranium at a concentration of 50 mg U g 21 tissue (Table 1 ). The configuration was also exposed to a 100 keV photon source, which corresponds to the energy of the peak of the natural background distribution. The results showed an enhancement of kidney dose of 0.61 % (standard uncertainty of 0.03 %) due to the presence of 50 mg U g 21 tissue. This monoenergetic field was assumed to represent the worst-case scenario in terms of photon energy, but it is acknowledged that irradiation PA may provide higher absorbed doses.
More realistic calculations were also performed by running the Monte Carlo models with the background gamma-ray energy distribution as the source term. In this case, the average enhancement to the absorbed dose to the kidneys was shown to be 0.17 % (+0.01), significantly reduced relative to that from monoenergetic exposures (Table 1) . Similarly, the average enhancement to the absorbed dose to the lungs was shown to be 0.150 % (+0.008). The explanation for this decrease for the energy distribution compared with monoenergetic photons is that a significant component of the natural background distribution corresponds to energies that contribute little to dose enhancement: the low-energy component of the field rapidly becomes attenuated and corresponds to where the differences between the photoelectric cross sections of uranium and tissue are smaller ( Figure 1) ; at high energies, Compton scattering becomes the dominant interaction.
The use of the natural background energy distribution measured at HPA, Chilton ( Figure 5 ) may not be representative of other locations. However, whatever fields are appropriate elsewhere, it is unlikely Figure 14 . Absorbed dose to the kidneys and lungs for isotropic irradiation with monoenergetic photons. The data for the kidneys are the average of the results for five different voxel phantoms (53) , while those for the lungs are taken from data published jointly by the ICRP (30) and ICRU (31) .
URANIUM IN THE BODY AND BACKGROUND RADIATION
that they would lead to enhancements greater than those resulting for the monoenergetic sources considered here, which are taken to be worst-case scenarios for isotropic exposures.
Binding to DNA
It is recognised by ICRP that the system of dosimetry recommended by them does not take account of the greater biological effectiveness of short-range electrons emitted on or close to DNA (54) . Because of the extremely short ranges of Coster-Kronig and outer shell Auger electrons in tissue (,1 mm), the location of the excited atom within a cell is important in determining the extent of DNA damage. This potential for harm is exacerbated when the atom is close to the DNA, because of the multiplicity of short-range electrons that could be emitted by a single atom. Thus, the standard assumption of uniform distribution of radionuclides throughout cells may underestimate or overestimate the relevant dose. A number of authors (for example, Hofer (55) ) discuss alternative dosimetry systems. Bingham et al. (56) referred in particular to the scheme used by the American Association of Physicists in Medicine (57, 58) , which recommends a radiation weighting factor of 20 for all Auger emitters for stochastic effects, for the proportion bound to DNA. Using this scheme, and assuming 100 % binding to DNA, Goddu et al. (59) considered the example of doses delivered within the testes from the Auger emitting radionuclides, 67 Ga, 99m Tc and 125 I, and showed that conventional dosimetry would underestimate the self-dose by factors of 4, 2 and 8 times, respectively. Actual increases in equivalent dose would be lower than calculated by Goddu et al. (59) because cross-fire doses from penetrating radiations from other tissues were not taken into account in this analysis.
It is possible that uranyl ions (UO 2 2þ ) may bind to DNA in living cells in place of Ca 2þ associated with phosphate groups. However, it is improbable that substantial numbers of these large ions would replace Ca 2þ under normal physiological conditions. For those uranyl ions that do become bound to DNA, the Auger and Coster-Kronig electrons emitted following photoelectric interactions could hence have a raised biological effectiveness, but the effective mean Z of a uranyl ion is 70 compared with the Z of 20 for calcium, which only gives a Z 4 ratio of 150. Consequently, the photoelectric enhancement ratio would not be as large as when uranium is considered to replace tissue.
Auger emission close to DNA
It has long been appreciated that substantially increased biological effectiveness could result from photoelectric events that take place in close proximity to DNA. Humm and Charlton (60) investigated the effects of irradiation using photons with energies just above and below the K-edges for medium-to high-Z elements that were incorporated into DNA. At energies just below the K-edge, Auger production is reduced so the dose to DNA in the cells is smaller, whereas above the K-edge, the highest energy Auger electrons can be produced and the dose to DNA is potentially much larger. Humm and Charlton anticipated that the local damage to DNA would be greatly enhanced by increasing the photon energy to greater than the K-edge energy, and that this effect could be calculated as increased dose to the DNA. They primarily considered bromine (Z¼35), because bromodeoxyuridine can be incorporated into DNA; bromodeoxyuridine is used as a potential means of enhancing the effectiveness of radiotherapy treatments. They modelled the radiation emitted from a bromine atom positioned on the axis of a long cylinder used to represent DNA, considering incident photons with energies just above and below the K-edge for photoelectron production, and found the short-range, strongly-ionising Auger electrons to be capable of producing doublestrand breaks. However, the number of 'hits' was very low, and they concluded that: 'the Auger cascades stimulated in this atom are relatively The percentage change (DD) in the absorbed dose to the organ caused by the addition of 50 mg of uranium per g of tissue is given (absolute standard deviation in parentheses). The results given are for the average of the six anthropomorphic phantoms used and the quoted uncertainties are the relative standard deviation based on the mean of the results for the six phantoms. These results are for isotropic irradiation.
unimportant'. Similar consideration of the effects of iodine (Z¼53) incorporated into DNA showed that, while photoelectric enhancement was greater than for bromine, fewer double-strand breaks actually occurred per Gy. This is because for iodine it is fluorescence rather than Auger emission that dominates the relaxation process following photoelectric interactions (61) (Figure 15 ). Humm and Charlton concluded that iodine would be less effective at depositing dose in DNA than bromine, despite its higher Z.
The greater fluorescence yields for higher Z atoms, relative to the Auger and Coster-Kronig yields that they are in competition with following K-shell vacancies (61) (Figure 15 ), causes energy to be deposited further from the initial photoelectric event than is the case in lower Z atoms, because the X-rays produced are generally longer in 'range' than the Auger and Coster-Kronig electrons. It is difficult to compare 'ranges' for electrons and photons, because electrons have reasonably well defined ranges, but photons are characterised by exponential attenuation with distance. However, a 1 keV electron has a range of 40 nm in tissue according to the range tables used within MCNP5, whereas a beam of 1 keV photons would be attenuated by 1.5 % by 40 nm of tissue (62) . However, it should also be noted that the X-ray from a given atomic transition has more energy than the Auger or Coster-Kronig electron that could otherwise be emitted. As a result, it can be inferred that the local biological impact close to high-Z elements will be less than would be implied by the Z 4 ratio with tissue, since much of the radiation emitted will be relatively longer in range.
While the photoelectric cross sections of elements increase strongly with increasing Z, the maximum energies and ranges of the Auger electrons that can result also increase. The Auger electron produced by vacancies in the K-shell of uranium has an energy of 75.4 keV (33) ; the range of such an electron in tissue is 90 mm (28) . However, lower energy Auger and Coster-Kronig electrons are subsequently produced by the outer shells of high-Z elements; these increase in number for each successive shell because one K-Auger causes two L-shell vacancies, and the Auger yield from outer shells is greater ( Figure 15 ). Hence, while each edge in the photoelectric cross section of uranium (Figure 1 ) represents the threshold energy for photoelectric interactions with a more tightly bound atomic shell, which in turn permits the emission of higher-energy, longer-range Auger electrons, it also represents the energy at which a higher multiplicity of Auger and Coster-Kronig electrons becomes possible.
While comparisons between uranium and bromine/iodine are interesting, it is perhaps more relevant in this context to compare uranium with Figure 15 . Auger electron yields from vacancies in the K, L 1 , L 2 and L 3 shells for atomic numbers from 5 to 110 (61) . Note that the L 1 -shell Auger yield is suppressed because of the relatively high Coster-Kronig yield for vacancies in that shell. Competition from Coster-Kronig emission means that the fluorescence y-axis should only be used for the K-shell de-excitations.
phosphorus. Phosphorus (Z¼15) is an important component of DNA and, while it is not a high-Z element, it is higher in Z than the other constituents of DNA and its photoelectric absorption cross section is hence relatively large. There is one phosphate group per nucleotide in the DNA molecule so there are two phosphorus atoms per base pair; there can be up to 220 million base pairs in a chromosome so there can be up to 440 million phosphorus atoms located within a chromosome. The ratio of the fourth powers of the atomic numbers of uranium and phosphorus is 1415. Hence, if a Z 4 relationship were substantiated, a chromosome would need to have over 300 000 uranium atoms bound to it to produce the same number of photoelectric events as might be expected from the exposure of its phosphorus. But, it is not sufficient simply to assume that the number of photoelectric events is the only parameter relevant for biological damage. The K-Auger electron from phosphorus has an energy of 1.83 keV (33) , so it is very short in range; this compares with 75.4 keV for uranium. The energy depositions from K-Auger electrons would therefore be more localised to the DNA in the case of phosphorus than for uranium. Moreover, because the Z of phosphorus is not high it produces very little fluorescence following photoelectric interactions with K-shell electrons; 93.7 % of K-shell vacancies in phosphorus produce Auger electrons whereas for uranium the figure is only 2.8 % (61) (Figure 15 , Table 2 ). The quantity of uranium atoms necessary for a K-shell Auger yield equivalent to that from chromosomal phosphorus would therefore be about 33 times greater than the number obtained from a simple division of their photoelectric cross sections.
When looking at bromine, Humm and Charlton (60) found that irradiation with photons just above and below the K-edge showed 'no difference in effect' between the two exposures in terms of their biological impact. While this does not prove that there would be no enhancement of the biological effect if uranyl ions were to bind to phosphate groups on DNA, the absence of an increase in the biological effectiveness of photons with energies just above the K-edge of bromine strongly suggests that these uranium atoms would also have no discernable effect. This conclusion is especially reinforced when it is considered that, in reality, there would be substantially fewer such co-located uranium atoms present than the number of phosphorus atoms in DNA.
MCNP5 calculations of localised electron dose from a uranium atom
To understand further the implications of uranyl ions bound to DNA, it is useful to look at the energy distributions of electrons and photons emitted from pure uranium following photon exposure. This has been done using MCNP5 (23) for a very simple geometry: a plane parallel beam of natural background photons was incident on a very thin disc of pure uranium, and the radiation emerging from the disc was tallied using an 'f4' fluence estimator. The mass thickness of uranium used was 10 28 g cm 2 , to ensure that the number of interactions of secondary radiation within the layer was negligible: it was important to ensure that the generated particles lost virtually no energy in exiting the layer, which was verified by noting that only 0.002 % of the electrons tallied were produced via e-e collisions, and only 10 25 % of the photons tallied were produced by bremsstrahlung. To ensure good statistical precision, the 'forced collision' method was used to ensure that every source photon would undergo an interaction, although the secondary particles generated would have very low weights; this method is well established and the adjustment of the particle 'weights' ensures that the tally estimate is unbiased. It should be noted that MCNP does not transport electrons and photons with energies less than 1 keV, instead it assumes absorption at the point of creation; those components of the true fluence hence do not escape from the uranium disc, and are therefore not included in the tallied distributions.
The secondary electron results have been processed to form a cumulative fluence-energy distribution (Figure 16 ), where the content of a bin is the sum of the electron fluences in all bins up to and including that bin, normalised to the total. The mean energy of each bin has then been transformed to the corresponding range in tissue (63) calculated by applying the continuous slowing-down approximation (CDSA), which is what is plotted on the x-axis as the 'radial distance'. These data (Figure 16) show that, for example: 50 % of the electrons transported travel .20 mm, which is equal to approximately two cell diameters, while 10 % travel over 100 mm, so their energy would be deposited in about 10 cell diameters. If the uranium atom were located at the centre of a 10 mm diameter cell, then 86 % of the transported electrons would have ranges that enabled them to escape from that cell.
In the context of biological significance, energy deposition is more relevant than particle fluence. To consider this, the secondary electron energy distribution generated from the thin uranium disc was used as a point source in a subsequent MCNP5 calculation. The point source was positioned at the centre of a set of concentric spherical shells of ICRU 4-element tissue, and the total energy deposited in each shell was tallied using an MCNP *f8 tally. The MCNP parameter ESTEP was set appropriately for each shell to ensure that sufficient substeps were taken by the electrons. The results were then converted into a cumulative energy deposition distribution, where the value in bin i equals the sum of the energies deposited in shell i and every shell inside it, normalised to the total; the total energies deposited within various radial displacements from the uranium atom can hence be plotted as fractions of the whole (Figure 16 ). Generally, statistical precisions from MCNP *f8 tallies are poorer than for other tallies; this necessitated the use of relatively thick shells, which in turn led to coarser radial distance binning than was used for the fluence distribution. Nevertheless, the energy deposition results closely match those for the fluence. Secondary photons created in the tissue were transported and included in the energy deposition results, but the photons generated originally from interactions within the uranium did not contribute because only the electron component of that field was used as the source in this latter calculation. Electrons and photons with energies less than 1 keV are not transported by MCNP, with their energy instead being deposited locally; any Auger electrons with energies less than 1 keV that might have resulted from a photoelectric event were consequently omitted from the source field used here. These results show that for the source field considered, just over 2 % of the total energy deposition takes place within 1 mm of the uranium atom: if the uranium were located at the centre of a cell of 10 mm radius, only 16 % of the energy would be deposited within it. So, if the uranium atom was bound to DNA, relatively little of the ionisation that it causes would be local to the molecule. The probability for double-strand breaks occurring would hence not be enhanced greatly by the co-location of uranium and DNA on the basis of these results.
However, these statements must be qualified by recognising the limitations of the electron and photon physics in MCNP5 and MCNPX, which include: † a minimum energy of 1 keV for particle transport, below which local absorption is assumed; † restricted relaxation processes following photoelectric events in which fluorescence generates at most two photons, while no more than one Auger electron is produced and † the initial energy of the simulated single Auger electron in a material is the highest or most probable Auger electron from the highest Z-element available in the material, after a Kshell vacancy.
These models can only be considered as very crude and have to be applied with care to get reliable answers. Despite these approximations, the macroscopic dose is calculated correctly by MCNP5 and MCNPX because the energy that would be carried by particles that are not transported is assumed to be deposited locally. However, when the dose deposition is studied for very small dimensions, there will be inaccuracies caused by the approximations in the particle transport. These will only be significant where the ranges of these low-energy particles are significant compared with the structure of the geometry that is being considered. The contribution to the absorbed dose represented by these discrepancies will be very small. Nevertheless Auger, Coster-Kronig and photoelectrons with energies ,1 keV could conceivably play a role on the microscopic or molecular level, i.e. on the scale of relevance to DNA, but it is difficult currently to ascertain the impact of this nontransportable component of the field; a full nanodosimetric analysis would be needed to consider properly the potential effects of these low-energy electrons, but such an approach is beyond the capabilities of contemporary general-purpose Monte Carlo modelling codes such as MCNP5. However, it is important to emphasise that this limitation does not lend weight to the suggestion that the exposure of uranyl ions must be damaging to co-located DNA: while that specific scenario cannot be modelled microdosimetrically by MCNP5, to assume that it causes significant detriment is still contrary to current biological, physical and epidemiological evidence. of absorbed dose was found for a natural background photon field. This could be increased to almost 0.7 % by choosing a 50 keV monoenergetic field, but that is not representative of natural background. Absorbed dose enhancements in the kidneys and lungs were correspondingly small when exposed to natural background photons, with results of þ0.17 % for the kidneys and þ0.15 % for the lungs found for the maximum non-fatal uranium concentrations. Higher values were calculated for the kidneys with 100 keV (0.6 %) and 120 keV (0.5 %) monoenergetic fields, but the absence of any strong Auger effects is evident from the reduction in the enhancement between these two energies, despite 120 keV being just above the K-Auger threshold energy. Calculations performed to derive the spatial distribution of energy deposition around a single atom show that it is not particularly localised: even though inverse square effects will affect the absorbed dose at a specific radial distance, most of the dose is deposited by electrons that are long-range relative to cell nucleus or whole cell dimensions. The directions in which the secondary particles are emitted from the atom will also not be correlated, so the probability of double-strand breaks from a single atom of uranium will remain a matter of chance, even if that atom emits more than one secondary electron that produces an ionisation very soon after emission. These calculations hence do not support any substantial effects resulting from uranium being bound to DNA.
There is currently no evidence from human data or animal experiments of unexpected radiotoxicity of uranium (11) . In this context, a recent study of French uranium workers showed no statistically significant increase in lung cancer risk among those workers exposed to the least soluble forms of uranium (70) . Moreover, the data contained in this review indicate that if any increase is shown by future studies, that increase would be more likely caused by the alpha decay of the uranium than by its interaction with natural background photons.
Overall, the modelling results, literature surveys and analysis of the physics, offer no support for there being a significant association between the presence of uranium in particulate or dissolved form and cancer induction via interactions with natural background photons. Interactions between uranium and natural background photons will increase absorbed dose locally by a very small amount, which could potentially increase the probability of double-strand breaks in DNA, but there is no evidence that this increase will be of any biological significance compared with the radiological detriment caused by the alpha decay of uranium.
